FDA Investigator Capri R Woolridge
Capri R Woolridge has inspections in 2 countries as of 29 Sep 2023. Capri R Woolridge has collaborated with a combinined 3179 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
105
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Italy
Co-Investigator(s):
Abha R Bommireddi,
Adam S Freeman,
Alec M O'neal,
Alexandra M Cossi,
Alexis R Ajello,
Alice A Blair,
Amanda N Schaupp,
Andersoneric,
Andrew B Slarve,
Andrew E Kay,
Andrew T Todd,
Andrew Tadros,
Angel K Sandhu,
Angela D Wise,
Annie H Lam,
Ashar P Parikh,
Azadeh A Yousefvand,
Bak,
Belinda E Clifton,
Blair,
Bruce D Broidy,
Camacho,
Carl Lee,
Carr,
Carr Sharpe,
Celeste K Wong,
Chloe Anne K Le,
Chloe Anne Leong,
Christine M Parmentier,
Christopher M Jenner,
Cindy W Lewis,
Courtney R Bolton,
Cynthia L Ford,
Damon A Growl,
Daniel C Geffin,
Daniel J Roberts,
Daniel Velasquez,
David A Lum,
Deborah K Richardson,
Deidre R Edwards,
Douglas J Snyder,
Douglas S Joslin,
Dustin P Tran,
Dustin R Abaonza,
Edna J Hidalgo,
Edward D Harris,
Edwards,
Elaine S Chow,
Elizabeth P Mayer,
Elodie Xtong Lin,
Emal Wahab,
Emmanuel O Kerry,
Eric J Heinze,
Eric W Anderson,
Erica Fernandez,
Erica R Pomeroy,
Estefania Fernandez,
Foley,
Frank P Bianco,
Gena M Mckahan,
Gina M Hall,
Greg K Keshishyan,
Humberto Z Gomez,
Ismael Garibay,
Jacqueline O Snell,
James C Lee, PharmD,
James C Yee,
James S Cartwright,
Jane Chen,
Jane G Choi,
Janice R Small,
Janice Wai,
Jazmine M Welcher,
Jeanmaire Hryshko,
Jeanne A Young,
Jeffrey M Watson,
Jeffrey W Shrifter, DPM,
Jennifer Crumb,
Jennifer L Degroot,
Jennifer L Johnson,
Jennifer S King,
Jessica B Darneille,
Jessica M Monteiro,
Joan T Briones,
Jocelyn T Ramos,
John A Gonzalez,
John A Liu,
John Cheung,
Jolene S Hedgecock,
Jonathon A Yenovkian,
Jorge L Bertran,
Joseph Tibay,
Juan A Morales,
Judy C Nepsa,
Kacie M Crowther,
Kaitlyn R Kornberg,
Karen D Phung,
Karla J Gibler,
Katie T Duong,
Keren Arkin,
Kevin Lee,
Kimberly L Anderson,
Kin T Moy,
Krystina M Jackson,
Larkin R Buckalew,
Laverne Puckett,
LCDR Jennifer H Rhyu,
Lee,
Leongc,
Lesley A Swanson,
Lija V Fellows,
Lila C Kraai,
Lillyj,
Linda S Shook,
Lorna F Jones,
Lorraine N Williams,
Lourdes Andujar,
LT Mark A Chen, MPH,
Luis A Solorzano,
Mabel M Lee,
Macropolk,
Maida Henesian (NMI),
Makia P Dove,
Maridali De Leon Torres,
Marie K Kinkade,
Marjorie D Santos,
Mark E Baldwin,
Mark I Nakano,
Mary C Acton,
Matthew K Wong,
Mcgrewp,
Megan E Kulas,
Mei Chiung J Huang,
Melissa N Simanton,
Melvin Dorin,
Michael D Kawalek,
Michelle L Tripp,
Naveen B Walker,
Nicole Yuen,
Noelani K Wu,
Nympha V Florendo,
Patrick E Gainer,
Paula E Davis Debella,
Peter E Baker,
Phillip J Sample,
Phung,
Quynh H Strandberg,
Randal Anderson,
Randall J Plunkett,
Randall P Zielinski,
Rebecca E Sulpacio,
Rebecca T Davis,
Roberta K Smith,
Robles,
Roger D Gawne,
Ronald P Boyce,
Ruark Lanham,
Rumany C Penn, PharmD,
Said H Muse,
Sandra S Saniga,
Sara M Richardson,
Sarah A Hassas,
Savannah E Samp,
Scott W Fox,
Sean P Desbrow,
Sergio Chavez (NMI),
Sharon L Shane,
Siobhan A Gallagher,
State Agency,
Stephanie A Slater, MS,
Stephanie Barragan,
Stephanie L Kelly,
Steve P Yost,
Steven B Chiu,
Steven J Branch,
Steven M Galvez,
Steven R Gillenwater,
Stuart W Russell,
Terrence Gee,
Thomas A Heller,
Thomas N Adjabeng,
Tiffany Chao,
Timothy C Grome,
Tomanik'e C Banks,
Travelle D Mason,
Victoria L Morgan,
Victoria Taylor,
Wen Jun Peng,
Wenting Lei,
Willemsj,
William J Foust,
William J Weis,
William V Millar,
Zachary A Bogorad
Capri R Woolridge's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2019 | EIR | T Marzetti Company-west - EIR, 2019-03-07 |
| April, 2018 | FDA 483 | Traditional Medicinals Inc - Form 483, 2018-04-12 |
| November, 2017 | FDA 483 | Mann Packing LLC. - Form 483, 2017-11-02 |
| November, 2017 | EIR | Mann Packing LLC. - EIR, 2017-11-02 |
| October, 2017 | FDA 483 | Golden Gate Soy Products, Inc. - Form 483, 2017-10-05 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more